Patents Assigned to Kardiatonos, Inc.
  • Publication number: 20180036285
    Abstract: A composition for treating multiple disease causes including a glycocalyx restoring and maintaining compound. A method of treating multiple disease causes, by administering a glycocalyx restoring and maintaining compound to an individual, restoring the glycocalyx, reversing inflammation, and reversing oxidative damage. A method of treating cardiovascular disease. A method of restoring the glycocalyx. A method of reversing inflammation. A method of reversing oxidative damage. A method of treating any disease involving a membrane that has a glycocalyx. A method of treating multiple disease causes. A method of restoring the structural and functional integrity of receptors in the glycocalyx. A method of restoring the glycocalyx and receptors therein and potentiating drug response. A composition for treating disease including the glycocalyx restoring and maintaining compound and an antibody.
    Type: Application
    Filed: April 20, 2016
    Publication date: February 8, 2018
    Applicant: Kardiatonos, Inc.
    Inventors: Josefino B. Tunac, Kenneth I. Kohn
  • Patent number: 9867842
    Abstract: A composition for treating multiple disease causes including a glycocalyx restoring and maintaining compound in an oral dosage form. A method of treating cardiovascular disease (CVD), by administering a glycocalyx restoring and maintaining compound to an individual suffering from CVD, restoring the glycocalyx, reversing inflammation, and reversing oxidative damage.
    Type: Grant
    Filed: November 10, 2016
    Date of Patent: January 16, 2018
    Assignee: Kardiatonos, Inc.
    Inventors: Josefino B. Tunac, Kenneth I. Kohn
  • Publication number: 20170080006
    Abstract: A composition for treating multiple disease causes including a glycocalyx restoring and maintaining compound in an oral dosage form. A method of treating cardiovascular disease (CVD), by administering a glycocalyx restoring and maintaining compound to an individual suffering from CVD, restoring the glycocalyx, reversing inflammation, and reversing oxidative damage.
    Type: Application
    Filed: November 10, 2016
    Publication date: March 23, 2017
    Applicant: Kardiatonos, Inc.
    Inventors: Josefino B. Tunac, Kenneth I. Kohn